chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever, Sinusitis - Information has been received from a physician concerning a 12 month old male, who on 21 Sep 2000 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation lot 633814/0990k.  On 28 Sep 2000. the patient experienced fever 102.5 F and congestion.  Subsequently, the patient recovered from the fever and congestion.  Other patients were reported with unspecified adverse events following vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation (MSD) waes 00101346.  In follow up the physician reported.  I was just reporting an increase frequency of issues with one lot of vaccine last year and do not have more details.  In follow up the records of testing prior to release of this have been checked by biologics Quality assurance and found to be satisfactory.  The lot comply with the standards of the center for biologics evaluation and research and was released.  No further information is available.
left arm is very hurt; Headache; This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EN6198, Expiration Date: not reported) via an unspecified route of administration, administered in left arm on 25Feb2021 (at the age of 39 years old) as dose 1, single for COVID-19 immunisation. The patient has no relevant medical history. The patient's concomitant medications were not reported. On 25Feb2021, the patient experienced that his left arm was very hurt and had a headache. No treatment was received for the adverse events. Outcome of all events was not recovered. No follow-up attempts are possible. No further information is expected.
onset 25FEB of h/a, swollen lips, stuffy nose, sore throat, stiffness, fever 100-ill for 7 days;now has a runny nose & a cold sore on lip;states may have had a little swelling in neck;no rash;
Geographic tongue, sores in mouth and tingly tongue and dry mouth - all of which have been on and off since the vaccine
Patient is under the age of 18 years old and was given this bi-valent. After speaking with the mother of the child there were no adverse events to be reported.
The May's menstrual period has last for 16 days; The April's menstrual period came 2 weeks earlier; Blood clot; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (heavy menstrual bleeding) and MENSTRUATION IRREGULAR  (menstruation irregular)(seriousness criterion medically significant), in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING (heavy menstrual bleeding) (seriousness criterion medically significant), and  MENSTRUATION IRREGULAR (menstruation irregular) (seriousness criterion medically significant) (The April's menstrual period came 2 weeks earlier) and OLIGOMENORRHOEA (The May's menstrual period has last for 16 days). At the time of the report, HEAVY MENSTRUAL BLEEDING (heavy menstrual bleeding), MENSTRUATION IRREGULAR (The April's menstrual period came 2 weeks earlier) and OLIGOMENORRHOEA (The May's menstrual period has last for 16 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Patient reports her menstrual period came 2 week earlier than she was expected, and her May's menstrual period has lasted 16 days at the moment of this call with blood cloths.  Concomitant product use was not provided by the reporter.    Treatment information was not provided.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
Moderna shot 1 on 3/24. Symptoms began on 4/4 and worsened until 4/9: Fatigue, chills, low fever, sore throat, no voice, body aches, dizziness, bad headache, no appetite. Went to the doc on 4/5 for rapid and pcr covid tests. Both negative. Unable to work or do any regular activities. Symptoms began getting better, but were still very present on 4/11. Went back to the doc to see if I should be taking anything besides mucinex. Rapid and pcr covid tested again - negative. 4/13 only fatigue. 4/14 all symptoms returned by the afternoon. Have had about 4 hours during which I could actually do anything. It?s possible that this has nothing to do with the vaccine, but it is very rare that I get sick like this, and i do think it is from the vaccine, so I think it?s worth reporting.
I started to notice pain and slight swelling in my left axilla less than a week after receiving my vaccine. There is also swelling at the injection site that goes away and returns.
Child developed a rash after going to daycare on Friday 6/29/18. Mom reports that there was no rash visible when she dropped her off. She did not have a fever and per mom and daycare provider she was acting normal. Rash was reported by daycare to mom about midday Friday and Mom called me about 1:30PM. Mom reported there were no chickenpox type lesions at that time. Called mom to check on child on Monday, 7/2/18 and rash is going away. Still no fever over the weekend although there are 2 "bug-bite" like spots on left thigh.
Patient came in with generalized weakness along with stroke at home. Patient is currently admitted. Positive on 11/15/2021
Patient experiencing sharp pains down right arm - experienced after flu shot primarily at night. Pt was going to PCP following my recommendation.
DEVELOPED DIZZINESS, EXTREME FATIGUE, CHILLS, WEAKNESS, NIGHTMARES AND ELEVATED BLOOD PRESSURES SINCE 1/12/2021 AT NIGHT. UNABLE TO GO TO WORK.
Mild swelling to right thigh day after administration. Second day after administration, itching sensation to right thigh, which child scratched. There was increased swelling and redness to right thigh. Child's mother adminsitered Tylenol PRN and placed cold compresses to site. At doctor's visit: right thigh swelling, skin tightness, and warmth noted. Temp 98.2F oral. Child walks with guarding and slight limp to right leg. Bactrim antibiotic course for 7 days provided. To take Tylenol PRN for pain. Discussed severe reactions and to go to ED if they occur. Stressed not to scratch right thigh.
it was rpt pt recv 1st dose varivax & 5th dose dtp & 4th dose opv 8//95 & on 5/19/98 pt devel a breakthrough varicella like rash. MD seen, had fever 101f. treated w/acyclovir. f/u info stated full blown severe chickenpox
CONFIRMED IMMUNOLOGICAL VACCINE FAILURE; This spontaneous report received from a patient concerned a 64 year old  male . The patient's height, and weight were not reported. The patient's concurrent conditions included: lupus, non-alcohol user, non-smoker, and suppressed immune system, and other pre-existing medical conditions included: The patient had no known allergies. The patient had no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 1805020 expiry: UNKNOWN) dose was not reported,1 total, administered on 02-APR-2021 to left arm as prophylactic vaccination. No concomitant medications were reported. On 18-AUG-2021, the patient had confirmed immunological vaccination failure. Patient did the Antibody test (NR: not provided) result were Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed immunological vaccination failure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0; 20210840763 -Covid-19 vaccine ad26.cov2. S- Confirmed immunological vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is un labelled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS, MEDICAL HISTORY
Reddish swelling, approximately 2" in diameter, within 3 days of vaccination.
This spontaneous report as received from a registered nurse refers to a multiple unspecified group of patients of unknown age and gender. On an unknown date the patients were vaccinated with PNEUMOVAX 23 (dose, frequency, lot #: not specified) that was improperly stored. Concomitant medication was not reported. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
evening of vax pt devel t104.3 & cried all noc w/high pitched screaming;16DEC96 pt wouldn't eat & was listless;pt went off all solid foods;w/in next 3mo pt lost all speech abilities;dx autism @ 2.5yr of age;exp grand mal sz;not develop OK;
Started feeling cold, shaky, and uneasy as I went to bed. When morning came felt lightheaded and dizzy. While trying to get dressed for the day I fainted and woke with a sore ankle. After that, went to the ER and found I had a spiral fracture. Needed surgery and was sent to Medical. After was laid up for 6weeks and took 6 weeks of physical therapy after. Healed nicely but still sore.
Patient said she had serious reaction back in '1988 and came to Employee Health to talk about receiving the Flu Vaccine so that she did not have to wear a surgical mask throughout the hospital (which is our policy). Because of the past HX in 1988 of serious reaction the staff determined that it is safer to administer the Vaccine in a monitored area, which is in the Urgent care of the hospital. FLUARIX PF was administered at 4:05 p.m. and I staid with her in the exam room during this time. Approx. 5 minutes after injection that she started feeling a dry mouth 'like cotton mouth' in her throat. She did end up getting some water and had no trouble swallowing it. She proceeded from a dry throat to a scratchy throat. At that time, she independently walked out to the nurses station herself to talk to a provider to inform her of how she was feeling. Returned to the room with the provider and the aide came in and checked her 02 saturations, which were stable. She continued to have a dry, rapsy throat. Staff registered her and a different male provider came to assess her. At that time, this writer left the exam room to report this to my supervisor.
This spontaneous report was received from a certified medical assistant via a medical representative concerning a patient of unknown age and gender. On an unknown date, approximately in September 2008 (about 4 years ago), the patient was vaccinated with the first dose of GARDASIL (dose, route and lot number unspecified as the patient had no record of first dose). No concomitant medications were reported. On 13-SEP-2012, the patient was given the second dose of GARDASIL (dose, route and lot number unspecified). No adverse event was reported. Additional information has been requested.
The vaccine administered  was given in high concentration. To the vaccine vial only was added 0.8 ml of  0.9 saline diluent, instead of 1.8 ml that should be added for the vial of  6 doses.
Started 10-12-10 fever, chills, headache, sore throat, runny nose throwing up.
tiny pin point of blood in his arm after the administration; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), in arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: VACCINATION SITE HAEMORRHAGE (non-serious), outcome "unknown", described as "tiny pin point of blood in his arm after the administration".  Additional Information: Reporter stated that for the first four doses, he did not have any problem during the administration. The people administering the vaccine had a good technique and there was only a tiny pin point of blood in his arm after the administration.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201177794 same patient/drug/event, different dose number;US-PFIZER INC-202201177795 same patient/drug/event, different dose number;US-PFIZER INC-202201177796 same patient/drug/event, different dose number;
My father became ill after the 2nd does and did not recover. His legs began to hurt. He found it hard to walk.  He didn?t want to go to the doctor from fear of COVID. But his legs began to swell and he couldn?t walk, so he went to ER on 4/18/2021 and released on 04/20/2021. He then went to his PCP on 04/28/2021. He went to see a cardiologist who said his heart was good on 04/30/2021. He passed away on 05/06/2021 in his sleep. Please help.
This spontaneous case reported by a consumer, describes the occurrence of chills, pyrexia (fever) and myalgia (body aches) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient had chills, pyrexia (fever) and myalgia (body aches). At the time of the report, chills, pyrexia (fever) and myalgia (body aches) outcome: unknown. Concomitant product use and treatment information not provided.
In either late August or early September 2022, I had fever, sweating, and body aches. It felt three times worse than the worst flu I have ever had. I went to a drive-thru testing facility and tested positive for COVID-19. I self-isolated and treated my symptoms with OTC TheraFlu. I called my doctor's office. I was advised to just take aspirin to manage my symptoms. I was also told that if my symptoms worsened, I could just call him back for further treatment options.  I stayed in bed for about four or five days. By the end of the first week, I began to feel better, though I still had a lot of fatigue.  Altogether, I self-isolated for two weeks and avoided contact with other people. After about two weeks of recuperation, I went back to work. I wore the mask at work and elsewhere in public, and I still wear a mask about 99% of the time.
Developed numbness in right shin that lasted approximately 2 weeks.  Also developed tingling in both legs that persisted for approximately the same amount of time.  Began taking alpha lipoic acid and vitamin B-12.  Also developed numbing headaches.  All of these have mostly stopped, although the numbing headaches (unlike anything experienced before) and tingling in legs still randomly occur.
I did not have a them to take a temp, but I know how it feels when you have a fever, I had chills and body aches and the body aches was the worst. Nobody could touch me because my skin hurt. I went to bed, did not eat that much. A couple days later the fever finally broke and I was fine.
she tested positive/stated she was asymptomatic; she tested positive/stated she was asymptomatic; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age (age 60, unit: unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration on 21Jan2021 (Batch/Lot Number: EL3249) at single dose, second dose via an unspecified route of administration on 11Feb2021 (Batch/Lot Number: EL9264) at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported.  The patient stated that she received both doses of the vaccine. She received the second dose yesterday (11Feb2021) and had to take a Covid test on the same day for an upcoming medical procedure and she tested positive. She asked if the vaccine can affect that test and have caused a false negative. She stated she was asymptomatic. She also asked if the vaccine would still work if someone was positive with Covid when they get the vaccine. The outcome of the event was unknown.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported drug ineffective and asymptomatic COVID-19 cannot be ruled out.
suspected vaccination failure; neuropathy in my hand; had shingles twice; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), post herpetic neuralgia (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the post herpetic neuralgia was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, post herpetic neuralgia and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles twice. The last one was horrific and left him/her with neuropathy in hand. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Pt is 9 days post-vaccination and has a raised, pruritic, erythematous lesion at site of injection measuring 8 x 4.5cm. Mild adverse event.
pt recv vax 10DEC96 & 11DEC96 pt woke up exp a steady pinch & tingling on pinky & ring finger on lt hadn & numbness;sx started in the wrist;when the wrist was pressed pt exp a lot of pain;pt had full use of hand & arm & total function;
On the evening of March 22, 2023, I was extremely tired. I was unable to walk up and down stairs without being exhausted. I was coughing and sneezing with nasal drip earlier in the week. I took NYQUIL to sleep. I slept for almost 19 hours. I was extremely tired and slept for three days. I had a little bit of muscle fatigue. I had head congestion that caused coughing and hard to breathe. I tested positive on the 23rd. I spoke to my doctor on that same night. I was able to complete the survey online and was prescribed PAXLOVID. I began to feel better after day 3 of PAXLOVID though I still had nasal drip.
Shingles after first dose; blister on ear; did not receive second dose due to COVID pandemic; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 83-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (Family History).   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles, blister and social problem. On an unknown date, the outcome of the shingles, blister and social problem were unknown.   It was unknown if the reporter considered the shingles and blister to be related to Shingrix.  Additional details were provided as follows: This case was reported by the patient herself. The age at vaccination was not reported for 1st dose and it was not applicable for 2nd dose. The patient received first dose of Shingrix vaccine over 18 months ago, possibly 2 years ago.  She stated she did not go back to receive her second dose due to the COVID pandemic. She mentioned she had a family history of shingles, and she also had shingles (her physician thought it was shingles; blister was on her ear) but did not recall if this occurred before or after her first dose of Shinhgrix. She did not have further information about her first dose. The reporter consented to follow up.
Expired Moderna Bivalent vaccine given on 2/28/2023.   This vaccine was drawn up on 2/20/2023 and was to be given by 2/21/2023.
LOSS OF BALANCE, LOSS OF COORDINATION WORSE WHILE EYES WERE CLOSED, OR IN THE DARK SAW PRIMARY CARE AND NEUROLOGIST. GOT BETTER DAY BY DAY. THEN SAW VISBIBULAR PT DR. NYSTAGNUS WAS THE DIAGNOSIS.  COGNOTIVE SYMPTOMS PAUSES IN MID SENTENCE, TROUBLE WITH EXECUTIVE FUNTIONING TROUBLE MULTI TASKING MEMORY, FILTERING TASK BRAING FOG. INCREASE NEED OF SLEEP
Left arm started to have tingling and numbness that spread throughout my shoulder down to the tips of my fingers. A burning, tingling, prickling sensation that''s also numbing at times as well and has; Left arm started to have tingling and numbness that spread throughout my shoulder down to the tips of my fingers. A burning, tingling, prickling sensation that''s also numbing at times as well and has; A burning, tingling, prickling sensation that's also numbing at times as well and has been occurring daily throughout the entire day since the 6thof October; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02Sep2021 14:00 (Lot number: FC3184) at the age of 46 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FA7485, Location of injection: Arm Left, Vaccine Administration Time: 02:00 PM), administration date: 12Aug2021, when the patient was 46 years old, for COVID-19 Immunization. The following information was reported: PARAESTHESIA (non-serious), HYPOAESTHESIA (non-serious) all with onset 06Oct2021 15:00, outcome "not recovered" and all described as "Left arm started to have tingling and numbness that spread throughout my shoulder down to the tips of my fingers. A burning, tingling, prickling sensation that''s also numbing at times as well and has"; BURNING SENSATION (non-serious) with onset 06Oct2021 15:00, outcome "not recovered", described as "A burning, tingling, prickling sensation that's also numbing at times as well and has been occurring daily throughout the entire day since the 6thof October". Therapeutic measures were not taken as a result of paraesthesia, hypoaesthesia, burning sensation.  Additional information: The patient did not receive any other vaccine in four weeks and any Other medications in two weeks. The patient did not had COVID prior vaccination and post vaccination, patient had not tested with Covid 19.No known allergies reported for the patient.   No follow-up attempts are possible. No further information is expected.